Blade Q1 revenue up 187% to $26.6M; net loss widens to $11.0M

Strata Critical Medical, Inc.

2022-Q1 EPS reported -$0.16 revenue$26,630,000

Total revenue $26.6M, +187% YoY; MediMobility and Jet revenue $22.1M, +186%.
Net loss $11.0M vs $4.2M; flight margin fell to 11% from 16%.
Adjusted EBITDA -$7.7M vs -$2.2M, driven by higher G&A and public company costs.
Blade Airport achieved record weekly run-rate of ~25,000 passengers in May.
Added 14 new organ transport clients in Q1; formed Blade Europe in Paris.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.